Moosheer Simone M, Waldschütz Wolfgang, Itariu Bianca K, Brath Helmut, Stulnig Thomas M
Christian Doppler Laboratory for Cardio-Metabolic Immunotherapy and Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Austria.
Diabetes Outpatient Clinic, Health Center South, Vienna, Austria.
Prim Care Diabetes. 2014 Dec;8(4):308-14. doi: 10.1016/j.pcd.2014.02.004. Epub 2014 Mar 19.
The current study aims to investigate practicability and effects of a combined dietary intervention with increased relative protein content supplemented with omega-3 polyunsaturated fatty acids (PUFA) on metabolic control and inflammatory parameters in a real life situation in type 2 diabetes patients.
In this observational study we advised thirty mostly obese patients with type 2 diabetes to follow a protein-enriched diet with carbohydrates of low glycemic index (low GI) and moderate fat reduction supplemented with omega-3 PUFA for 24 weeks. Primary efficacy parameter was the change in HbA1c; secondary parameters included changes in systemic inflammation (measured by ultrasensitive C-reactive protein, usCRP), body weight, waist circumference, fat mass. The study is registered at clinicaltrials.gov (NCT01474603).
The dietary intervention significantly reduced the primary efficacy variable HbA1c from a baseline value of 63±11mmol/mol to 59±14mmol/mol (P=0.033) and 56±12mmol/mol (P=0.001) after 12 and 24 weeks, respectively. In addition, usCRP decreased significantly at 24 weeks (P=0.039). Waist circumference, an important indicator for cardiometabolic-risk and silent inflammation, decreased from baseline 116.0±14.1cm to 114.9±13.5cm (P=0.019), 114.0±14.4cm (P=0.001), and 112.7±13.4cm (P=0.049), after 3, 12 and 24 weeks, respectively.
Counseling a protein enriched and low glycemic index diet supplemented with long-chain omega-3 PUFA in a real-life clinical setting improves glycemic control and also reduces waist circumference and silent inflammation in overweight or obese patients with type 2 diabetes.
本研究旨在探讨在现实生活中,增加相对蛋白质含量并补充ω-3多不饱和脂肪酸(PUFA)的联合饮食干预对2型糖尿病患者代谢控制和炎症参数的实用性及效果。
在这项观察性研究中,我们建议30名大多为肥胖的2型糖尿病患者遵循富含蛋白质、低升糖指数(低GI)碳水化合物且适度减少脂肪并补充ω-3 PUFA的饮食,为期24周。主要疗效参数为糖化血红蛋白(HbA1c)的变化;次要参数包括全身炎症(通过超敏C反应蛋白,即usCRP测量)、体重、腰围、脂肪量的变化。该研究已在ClinicalTrials.gov注册(NCT01474603)。
饮食干预使主要疗效变量HbA1c从基线值63±11mmol/mol分别在12周和24周后显著降至59±14mmol/mol(P = 0.033)和56±12mmol/mol(P = 0.001)。此外,usCRP在24周时显著下降(P = 0.039)。腰围是心血管代谢风险和隐性炎症的重要指标,在3周、12周和24周后分别从基线的116.0±14.1cm降至114.9±13.5cm(P = 0.019)、114.0±14.4cm(P = 0.001)和112.7±13.4cm(P = 0.049)。
在现实临床环境中,为超重或肥胖的2型糖尿病患者提供富含蛋白质且低升糖指数并补充长链ω-3 PUFA的饮食咨询,可改善血糖控制,并减少腰围和隐性炎症。